Tuesday, March 04, 2025 | 07:10 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

ITRDC plans to raise Rs 500 cr to develop drug combination for tuberculosis

According to WHO's Global Tuberculosis Report 2016, India has the highest burden of TB in the world

ITRDC plans to raise Rs 500 cr to develop drug combination for tuberculosis
Premium

Sharath Chowdary Hyderabad
India TB Research and Development Corporation (ITRDC), an initiative of Indian Council of Medical Research (ICMR), is planning to raise Rs 500 crore to develop a drug combination to cure the dreaded disease tuberculosis (TB) in the next 5-7 years.

"The ITRDC needs Rs 500-crore fund to create new treatment regimen for multi-drug-resistant TB and extensively drug resistant TB. The government is likely to grant 50 per cent of the fund while the rest of Rs 250 crore will be raised from other agencies," Department of Health Research secretary and ICMR director-general Soumya Swaminathan told Business Standard.

Swaminathan said that

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in